Anna S. Krivonogova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anna S. Krivonogova has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Albina G. Isaeva
Ural Federal Agrarian Scientific Research Centre, Ural Branch of the Russian Academy of Sciences
3 shared publications - Olga V. Sokolova
Ural Federal Agrarian Scientific Research Center, Ural Branch of the Russian Academy of Sciences
3 shared publications - Vladlena D. Zubareva
Ural Federal Agrarian Scientific Research Center, Ural Branch of the Russian Academy of Sciences
3 shared publications - Irina Mikhailovna Donnik
Ural Federal Agrarian Scientific Research Centre, Ural Branch of the Russian Academy of Sciences
2 shared publications - Maria Nikolaevna Isakova
Ural Federal Agrarian Research Center, Ural Branch of the Russian Academy of Sciences
2 shared publications - Maxim Petropavlovskiy
Ural Federal Agrarian Scientific Research Centre, Ural Branch of the Russian Academy of Sciences
2 shared publications
Latest Publications
- 5 June 2026
- Published by Kemerovo State University in Foods and Raw Materials
- Vol. 15 (2) , 257-269
Genetic heterogeneity and pathogenetic mechanisms of bovine leukemia virus
Bovine leukemia virus is an RNA virus of the Retrovivridae family. It causes a chronic infectious disease in farm animals that poses a serious threat to global cattle farming. According to phylogenetic studies, the pathogen is classified into 12 genotypes. This comprehensive bioinformatic analysis featured new bovine leukemia virus isolates (n = 57) sampled from various regions of the Russian Federation with different epizootic situations. The analysis featured both new sequences and old samples from Russia available in the National Center for Biotechnology Information. This large-scale approach made it possible to cover all known genotypes. G4 genotype was associated with major amino acid substitutions in gp51 (T47A, A73P, R121H in epitope G; S56F in epitope H; I144T in ND2; D166G in CD8+). These substitutions provide a selective advantage through immune evasion mechanisms, including escape from humoral immunity, impaired T-cell recognition, and increased receptor affinity. G4 also correlated with rapid progression. The rapid replacement of G7 by G4 in the Tyumen Region and the general dominance of G4 in Russia were due to a more aggressive course of infection resulting from the genetic ability of the pathogen to adapt to the host immune system. The obtained data underscore the necessity of developing genotype-specific diagnostic systems and implementing routine molecular-genetic monitoring to control the spread of bovine leukemia virus. New data on genetic variability and its impact on genotype-phenotype correlations may help curb the infection.
- 5 June 2026
- Published by Kemerovo State University in Foods and Raw Materials
- Vol. 15 (2) , 257-269
Genetic heterogeneity and pathogenetic mechanisms of bovine leukemia virus
Bovine leukemia virus is an RNA virus of the Retrovivridae family. It causes a chronic infectious disease in farm animals that poses a serious threat to global cattle farming. According to phylogenetic studies, the pathogen is classified into 12 genotypes. This comprehensive bioinformatic analysis featured new bovine leukemia virus isolates (n = 57) sampled from various regions of the Russian Federation with different epizootic situations. The analysis featured both new sequences and old samples from Russia available in the National Center for Biotechnology Information. This large-scale approach made it possible to cover all known genotypes. G4 genotype was associated with major amino acid substitutions in gp51 (T47A, A73P, R121H in epitope G; S56F in epitope H; I144T in ND2; D166G in CD8+). These substitutions provide a selective advantage through immune evasion mechanisms, including escape from humoral immunity, impaired T-cell recognition, and increased receptor affinity. G4 also correlated with rapid progression. The rapid replacement of G7 by G4 in the Tyumen Region and the general dominance of G4 in Russia were due to a more aggressive course of infection resulting from the genetic ability of the pathogen to adapt to the host immune system. The obtained data underscore the necessity of developing genotype-specific diagnostic systems and implementing routine molecular-genetic monitoring to control the spread of bovine leukemia virus. New data on genetic variability and its impact on genotype-phenotype correlations may help curb the infection.
- Open Access
- 17 September 2025
- Published by FGI Federal Centre for Animal Health (FGI ARRIA) in Veterinary Science Today
- Vol. 14 (3) , 294-301
Microbial species diversity and antibiotic-resistant Enterobacteriaceae spread on dairy farms
Introduction. Bacterial communities significantly affect the overall productivity of agricultural establishments, as animal health, milk production, and food quality and safety depend on them. Zoonotic bacteria not only have a negative impact on animal health, but also pose a risk to public health, so monitoring of the microbial species diversity on dairy farms to determine the predominant pathogen species and antibiotic resistance profiles is essential.Objective. Study of bacterial species diversity on a dairy farm and monitoring of antibiotic resistance spread in Escherichia coli and Proteus mirabilis isolates in order to enable timely development of measures containing the spread of antibiotic-resistant microorganisms.Materials and methods. To achieve this goal, microorganisms were identified by MALDI-ToF mass spectrometry and antibiotic susceptibility of the isolated cultures was determined using the disc diffusion test.Results. The species diversity of microorganisms isolated from samples of cattle limb wound exudates, feces, and feed was established. Opportunistic and pathogenic Escherichia coli and Proteus mirabilis turned out to be the predominant microorganisms, and their antibiotic resistance profiles were determined. One of the Escherichia coli isolates was found to be multi-resistant; only a combination of amoxicillin and clavulanic acid proved effective in inhibiting the growth of this culture. A large proportion of Proteus mirabilis isolates were resistant to drugs included in the group of fluoroquinolones and sensitive to all other tested antibacterial agents.Conclusion. The factors influencing the microbial species diversity in wound exudate, feces and feed were reported. Determination of Enterobacteriaceae antibiotic resistance profiles will allow for the rotation of antibacterial drugs on the studied livestock farms.
- 17 September 2025
- Published by FGI Federal Centre for Animal Health (FGI ARRIA) in Veterinary Science Today
- Vol. 14 (3) , 294-301
Open AccessMicrobial species diversity and antibiotic-resistant Enterobacteriaceae spread on dairy farms
Introduction. Bacterial communities significantly affect the overall productivity of agricultural establishments, as animal health, milk production, and food quality and safety depend on them. Zoonotic bacteria not only have a negative impact on animal health, but also pose a risk to public health, so monitoring of the microbial species diversity on dairy farms to determine the predominant pathogen species and antibiotic resistance profiles is essential.Objective. Study of bacterial species diversity on a dairy farm and monitoring of antibiotic resistance spread in Escherichia coli and Proteus mirabilis isolates in order to enable timely development of measures containing the spread of antibiotic-resistant microorganisms.Materials and methods. To achieve this goal, microorganisms were identified by MALDI-ToF mass spectrometry and antibiotic susceptibility of the isolated cultures was determined using the disc diffusion test.Results. The species diversity of microorganisms isolated from samples of cattle limb wound exudates, feces, and feed was established. Opportunistic and pathogenic Escherichia coli and Proteus mirabilis turned out to be the predominant microorganisms, and their antibiotic resistance profiles were determined. One of the Escherichia coli isolates was found to be multi-resistant; only a combination of amoxicillin and clavulanic acid proved effective in inhibiting the growth of this culture. A large proportion of Proteus mirabilis isolates were resistant to drugs included in the group of fluoroquinolones and sensitive to all other tested antibacterial agents.Conclusion. The factors influencing the microbial species diversity in wound exudate, feces and feed were reported. Determination of Enterobacteriaceae antibiotic resistance profiles will allow for the rotation of antibacterial drugs on the studied livestock farms.
- Open Access
- 14 September 2024
- Published by FGI Federal Centre for Animal Health (FGI ARRIA) in Veterinary Science Today
- Vol. 13 (3) , 203-213
Alternative treatment methods for bovine mastitis: prospects and limitations (review)
Mastitis remains the most common problem of dairy industry despite the preventive measures and treatment schemes being developed. Antibacterial drugs remain first line agents for therapy of the mammary gland inflammatory diseases in animals. Taking into account the risks associated with antibiotic therapy, such as decreased drug effectiveness due to occurrence of bacterial resistant strains, food safety issues, environmental impact and restrictions on the use of antibacterial drugs in veterinary medicine, an increasing number of scientific studies are addressing new therapeutic agents that can serve as an alternative to conventional therapy. The aim of this review is to give an idea of currently available literature data on alternative methods for the prevention and treatment of mastitis in cattle that are not associated with antibiotics. In general, a significant number of in vitro studies aimed at finding new effective and safe drugs are yielding promising results. This review describes the following alternative remedies: probiotics, bacteriocins, bacteriophages, phage enzymes (endolysins), nanoparticles, plant extracts, essential oils and immunobiological agents (vaccines). Understanding the mechanisms of their action will allow recommending the best treatment option for mastitis in each specific case. These treatment methods can potentially reduce use of antibiotics and increase animal productivity, however more in vivo studies are needed to prove the effectiveness of antibiotics used directly in the conditions of farm settings.
- 14 September 2024
- Published by FGI Federal Centre for Animal Health (FGI ARRIA) in Veterinary Science Today
- Vol. 13 (3) , 203-213
Open AccessAlternative treatment methods for bovine mastitis: prospects and limitations (review)
Mastitis remains the most common problem of dairy industry despite the preventive measures and treatment schemes being developed. Antibacterial drugs remain first line agents for therapy of the mammary gland inflammatory diseases in animals. Taking into account the risks associated with antibiotic therapy, such as decreased drug effectiveness due to occurrence of bacterial resistant strains, food safety issues, environmental impact and restrictions on the use of antibacterial drugs in veterinary medicine, an increasing number of scientific studies are addressing new therapeutic agents that can serve as an alternative to conventional therapy. The aim of this review is to give an idea of currently available literature data on alternative methods for the prevention and treatment of mastitis in cattle that are not associated with antibiotics. In general, a significant number of in vitro studies aimed at finding new effective and safe drugs are yielding promising results. This review describes the following alternative remedies: probiotics, bacteriocins, bacteriophages, phage enzymes (endolysins), nanoparticles, plant extracts, essential oils and immunobiological agents (vaccines). Understanding the mechanisms of their action will allow recommending the best treatment option for mastitis in each specific case. These treatment methods can potentially reduce use of antibiotics and increase animal productivity, however more in vivo studies are needed to prove the effectiveness of antibiotics used directly in the conditions of farm settings.
- 11 January 2024
- Published by Elsevier in Radiation Physics and Chemistry
- Vol. 217, 111528
Radiation surface antimicrobial processing of poultry meat and by-products using the nanosecond low-energy electron beam
- 11 January 2024
- Published by Elsevier in Radiation Physics and Chemistry
- Vol. 217, 111528
Radiation surface antimicrobial processing of poultry meat and by-products using the nanosecond low-energy electron beam
- Open Access
- 30 December 2023
- Published by Kemerovo State University in Food Processing: Techniques and Technology
- Vol. 53 (4) , 710-717
Antibiotic Resistance of Enterobacteriaceae in Microbiomes Associated with Poultry Farming
Antibiotics have long been overused for non-therapeutic purposes. As a result, Escherichia, Enterobacter, Klebsiella, and Proteus in avian microbiomes have become reservoirs for genetic determinants of resistance, thus spreading resistance to antibiotics and contaminating raw materials and finished products. The food industry is looking for alternative means to preserve health and maintain high productivity of commercial poultry, e.g., probiotics, phytobiotics, organic acids, etc. The research featured the effect of antibiotics and phytobiotics on enteropathogenic bacteria in the microbiomes of broiler chicken. Escherichia coli bacteria were cultivated in vitro in subthreshold concentrations on nutrient media with antibiotics for 37 days to study the effect of low doses of antibiotics on the sensitivity of isolates. The study involved microbiocenoses of broiler chicken that received avilamycin A and a phytobiotic based on Brassica juncea, Linum usitatissimum, and Nigella sativa L. A set of experiments covered the species composition of opportunistic Enterobacteriaceae, the phenotypic sensitivity to antibiotics, and the genetic determinants of resistance, as well as the antimicrobial potential of phytobiotics. E. coli developed no resistance for 37 days when the antibiotic dose remained below minimal inhibitory. Opportunistic gram-negative Enterobacterales predominated in all litter samples. E. coli, Klebsiella pneumoniae, and Proteus mirabilis accounted for more than 30% of all isolated strains. Avilamycin A and the phytobiotic affected the coccal microflora but had no effect on the genus-species composition of Enterobacteriaceae. Litter samples from both experimental and control groups demonstrated K. pneumoniae with severe phenotypic resistance to ciprofloxacin, as well as blaDHA genes. In broiler farming, maintenance and circulation of resistance agents depends on litter microbiota. In this research, the chicken that received the phytobiotic showed the lowest level of resistance to ciprofloxacin while the groups that received avilamycin A had the highest resistance results. During a broiler’s life span, bacteria with no active resistance determinants in their genome remained sensitive to antibiotics, even though the contact with the latter was constant. Phytobiotics showed good prospects for broiler farming as food additive that could reduce and eventually eliminate the intake of antibiotics.
- 30 December 2023
- Published by Kemerovo State University in Food Processing: Techniques and Technology
- Vol. 53 (4) , 710-717
Open AccessAntibiotic Resistance of Enterobacteriaceae in Microbiomes Associated with Poultry Farming
Antibiotics have long been overused for non-therapeutic purposes. As a result, Escherichia, Enterobacter, Klebsiella, and Proteus in avian microbiomes have become reservoirs for genetic determinants of resistance, thus spreading resistance to antibiotics and contaminating raw materials and finished products. The food industry is looking for alternative means to preserve health and maintain high productivity of commercial poultry, e.g., probiotics, phytobiotics, organic acids, etc. The research featured the effect of antibiotics and phytobiotics on enteropathogenic bacteria in the microbiomes of broiler chicken. Escherichia coli bacteria were cultivated in vitro in subthreshold concentrations on nutrient media with antibiotics for 37 days to study the effect of low doses of antibiotics on the sensitivity of isolates. The study involved microbiocenoses of broiler chicken that received avilamycin A and a phytobiotic based on Brassica juncea, Linum usitatissimum, and Nigella sativa L. A set of experiments covered the species composition of opportunistic Enterobacteriaceae, the phenotypic sensitivity to antibiotics, and the genetic determinants of resistance, as well as the antimicrobial potential of phytobiotics. E. coli developed no resistance for 37 days when the antibiotic dose remained below minimal inhibitory. Opportunistic gram-negative Enterobacterales predominated in all litter samples. E. coli, Klebsiella pneumoniae, and Proteus mirabilis accounted for more than 30% of all isolated strains. Avilamycin A and the phytobiotic affected the coccal microflora but had no effect on the genus-species composition of Enterobacteriaceae. Litter samples from both experimental and control groups demonstrated K. pneumoniae with severe phenotypic resistance to ciprofloxacin, as well as blaDHA genes. In broiler farming, maintenance and circulation of resistance agents depends on litter microbiota. In this research, the chicken that received the phytobiotic showed the lowest level of resistance to ciprofloxacin while the groups that received avilamycin A had the highest resistance results. During a broiler’s life span, bacteria with no active resistance determinants in their genome remained sensitive to antibiotics, even though the contact with the latter was constant. Phytobiotics showed good prospects for broiler farming as food additive that could reduce and eventually eliminate the intake of antibiotics.
- 1 January 2022
- Published by FGI Federal Centre for Animal Health (FGI ARRIA) in Veterinary Science Today
- Vol. 11 (1)
Antimicrobial resistance in clinical Escherichia coli isolates obtained from animals
Представлены данные о фенотипической и генотипической характеристике антибиотикорезистентности клинических изолятов Escherichia coli, выделенных из микробных биотопов (секрет молочной железы, цервикальные смывы) крупного рогатого скота. Исследовано 127 изолятов кишечной палочки, в том числе 44 - из секрета молочной железы, 83 - из цервикальных смывов. Антибиотикорезистентность культур изучали диско-диффузионным методом, минимальные ингибирующие концентрации антибактериальных препаратов определяли методом серийных разведений, гены резистентности детектировали с помощью полимеразной цепной реакции. В результате исследований показано широкое распространение изолятов микроорганизмов с фенотипом резистентности к ансамицинам (рифампицину), полусинтетическим пенициллинам (ампициллину и амоксициллину), тетрациклинам (доксициклину). Меньший уровень устойчивости изоляты проявляли к макролидам (азитромицину), амфениколам (левомицетину) и аминогликозидам (тобрамицину). Установлено, что клинические изоляты Escherichia coli чувствительны к цефалоспоринам III поколения и противомикробным средствам из группы фторхинолонов. Однако регистрация у 28,46% культур промежуточной резистентности к цефалоспоринам III поколения и выявление гена blaDHA, ассоциированного с развитием устойчивости к данной группе препаратов в 49,02% образцов ДНК эшерихий, изолированных из секрета молочной железы, не позволяют рекомендовать их в качестве препаратов выбора. Отсутствие гена VIM, кодирующего продукцию карбапенемаз в ДНК у выделенных изолятов, и низкий уровень фенотипической устойчивости (10,22% изолятов из цервикальных смывов) может служить одной из предпосылок для рекомендации использования карбапенемов 1-го ряда в качестве препаратов выбора для терапии заболеваний животных, ассоциированных с Escherichia coli, наряду со фторхинолонами, однако только в качестве препаратов резерва. Установлено, что выделенные изоляты Escherichia coli демонстрировали большую чувствительность к комбинированным противомикробным лекарственным средствам в сравнении с...
- 1 January 2022
- Published by FGI Federal Centre for Animal Health (FGI ARRIA) in Veterinary Science Today
- Vol. 11 (1)
Antimicrobial resistance in clinical Escherichia coli isolates obtained from animals
Представлены данные о фенотипической и генотипической характеристике антибиотикорезистентности клинических изолятов Escherichia coli, выделенных из микробных биотопов (секрет молочной железы, цервикальные смывы) крупного рогатого скота. Исследовано 127 изолятов кишечной палочки, в том числе 44 - из секрета молочной железы, 83 - из цервикальных смывов. Антибиотикорезистентность культур изучали диско-диффузионным методом, минимальные ингибирующие концентрации антибактериальных препаратов определяли методом серийных разведений, гены резистентности детектировали с помощью полимеразной цепной реакции. В результате исследований показано широкое распространение изолятов микроорганизмов с фенотипом резистентности к ансамицинам (рифампицину), полусинтетическим пенициллинам (ампициллину и амоксициллину), тетрациклинам (доксициклину). Меньший уровень устойчивости изоляты проявляли к макролидам (азитромицину), амфениколам (левомицетину) и аминогликозидам (тобрамицину). Установлено, что клинические изоляты Escherichia coli чувствительны к цефалоспоринам III поколения и противомикробным средствам из группы фторхинолонов. Однако регистрация у 28,46% культур промежуточной резистентности к цефалоспоринам III поколения и выявление гена blaDHA, ассоциированного с развитием устойчивости к данной группе препаратов в 49,02% образцов ДНК эшерихий, изолированных из секрета молочной железы, не позволяют рекомендовать их в качестве препаратов выбора. Отсутствие гена VIM, кодирующего продукцию карбапенемаз в ДНК у выделенных изолятов, и низкий уровень фенотипической устойчивости (10,22% изолятов из цервикальных смывов) может служить одной из предпосылок для рекомендации использования карбапенемов 1-го ряда в качестве препаратов выбора для терапии заболеваний животных, ассоциированных с Escherichia coli, наряду со фторхинолонами, однако только в качестве препаратов резерва. Установлено, что выделенные изоляты Escherichia coli демонстрировали большую чувствительность к комбинированным противомикробным лекарственным средствам в сравнении с...
- Open Access
- 9 December 2019
- Published by Urals State Agrarian University in Agrarian Bulletin of the Urals
- Vol. 191 (12) , 40-44
Features of the preparation of biological material for genome editing in cattle
To carry out genome editing in cattle, an effective and well-functioning system for obtaining gametes, fertilizing eggs and their cryopreservation is necessary. Aim of the work: review and research of present-day existing methods of obtaining, insemination and cryopreservation of donor material, in order to provide genome editing in cows. Methods and materials. The work is completed according to the theme No. 0532-2019-0001 “Development of complex technology of marker-based genome selection of agricultural animals” within State Order of Ministry of Education and Science of the Russian Federation. The analysis of open scientific literature on the issues of in vitro fertilization in animals, cryopreservation of oocytes and embryons, sperm preparation and methods of insemination of cows’ oocytes, and cryopreservation of oocytes and embryons of animals is done. Features of the preparation of biological material of cattle for genome editing by microinjection into ooplasm are described. Results of research and duscussion. At present time there are two ways to obtain donor material from cattle: from live animals and taking ovaries after slaughtering cows. Material transportation is carried out at a temperature of 30–37 °C depending on the distance to the laboratory and expected time period of transportation. Oocyte-cumulus complexes can be removed by ovarian dissection and aspiration of visible follicles. In both cases, immature eggs are predominantly obtained. Subsequent ripening is carried out in vitro using special media in a CO2 incubator. The culture medium for oocyte maturation should contain hormones that mimic the peak of LH (luteinizing hormone), which occurs in vivo during the maturation of oocytes before ovulation. To accumulate a certain number of eggs at the stage of MII, it is recommended to carry out their cryopreservation by the method of vitrification, having previously released the oocyte from the cumulus cells. After thawing, oocytes need to be incubated for 2–3 hours 38.5 °C in 5–6.5% CO2 to restore the spindle. In order to make editing more effective, the introduction of genetic material is recommended to be carried out in parallel with the fertilization method “icsi”. In humans, mice and rabbits, an injection of sperm into the cytoplasm is sufficient to activate the oocyte, however, in cattle, just micro-injection of the sperm is not enough and often the male pronucleus does not form. To solve the problem, various methods are used, including freezing-thawing of sperm, resulting in damage of a membrane, or addition of heparin-glutathione into the medium that increases decondensation of the sperm DNA.
- 9 December 2019
- Published by Urals State Agrarian University in Agrarian Bulletin of the Urals
- Vol. 191 (12) , 40-44
Open AccessFeatures of the preparation of biological material for genome editing in cattle
To carry out genome editing in cattle, an effective and well-functioning system for obtaining gametes, fertilizing eggs and their cryopreservation is necessary. Aim of the work: review and research of present-day existing methods of obtaining, insemination and cryopreservation of donor material, in order to provide genome editing in cows. Methods and materials. The work is completed according to the theme No. 0532-2019-0001 “Development of complex technology of marker-based genome selection of agricultural animals” within State Order of Ministry of Education and Science of the Russian Federation. The analysis of open scientific literature on the issues of in vitro fertilization in animals, cryopreservation of oocytes and embryons, sperm preparation and methods of insemination of cows’ oocytes, and cryopreservation of oocytes and embryons of animals is done. Features of the preparation of biological material of cattle for genome editing by microinjection into ooplasm are described. Results of research and duscussion. At present time there are two ways to obtain donor material from cattle: from live animals and taking ovaries after slaughtering cows. Material transportation is carried out at a temperature of 30–37 °C depending on the distance to the laboratory and expected time period of transportation. Oocyte-cumulus complexes can be removed by ovarian dissection and aspiration of visible follicles. In both cases, immature eggs are predominantly obtained. Subsequent ripening is carried out in vitro using special media in a CO2 incubator. The culture medium for oocyte maturation should contain hormones that mimic the peak of LH (luteinizing hormone), which occurs in vivo during the maturation of oocytes before ovulation. To accumulate a certain number of eggs at the stage of MII, it is recommended to carry out their cryopreservation by the method of vitrification, having previously released the oocyte from the cumulus cells. After thawing, oocytes need to be incubated for 2–3 hours 38.5 °C in 5–6.5% CO2 to restore the spindle. In order to make editing more effective, the introduction of genetic material is recommended to be carried out in parallel with the fertilization method “icsi”. In humans, mice and rabbits, an injection of sperm into the cytoplasm is sufficient to activate the oocyte, however, in cattle, just micro-injection of the sperm is not enough and often the male pronucleus does not form. To solve the problem, various methods are used, including freezing-thawing of sperm, resulting in damage of a membrane, or addition of heparin-glutathione into the medium that increases decondensation of the sperm DNA.